Hydroxyimino-[methyl-[3-(methylamino)propyl]amino]-oxidoazanium
C5H14N4O2 — CID 135521196
Data last refreshed: (MolForge compound catalog, from PubChem)
About Hydroxyimino-[methyl-[3-(methylamino)propyl]amino]-oxidoazanium
Hydroxyimino-[methyl-[3-(methylamino)propyl]amino]-oxidoazanium (PubChem CID 135521196) has the molecular formula C5H14N4O2 and a molecular weight of 162.19 g/mol. Its IUPAC name is hydroxyimino-[methyl-[3-(methylamino)propyl]amino]-oxidoazanium.
Molecular Properties
| Compound Name | Hydroxyimino-[methyl-[3-(methylamino)propyl]amino]-oxidoazanium |
|---|---|
| PubChem CID | 135521196 |
| Molecular Formula | C5H14N4O2 |
| Molecular Weight | 162.19 g/mol |
| Exact Mass | 162.11 |
| IUPAC Name | hydroxyimino-[methyl-[3-(methylamino)propyl]amino]-oxidoazanium |
| SMILES | CNCCCN(C)[N+]([O-])=NO |
| InChI | InChI=1S/C5H14N4O2/c1-6-4-3-5-8(2)9(11)7-10/h6,10H,3-5H2,1-2H3 |
| InChIKey | BPBUJYBQUBMWDT-UHFFFAOYSA-N |
| XLogP | -0.21 |
| TPSA | 73.93 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 11 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 162.19 |
| LogP ≤ 5 | -0.21 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135521196 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.